^
    No biomarker
    Soft Tissue Sarcoma
    olaratumab
    Sensitive
    :
    A1
    No biomarker
    Soft Tissue Sarcoma
    trabectedin
    Sensitive
    :
    A1
    No biomarker
    Soft Tissue Sarcoma
    pazopanib
    Sensitive
    :
    A1
    No biomarker
    Soft Tissue Sarcoma
    tazemetostat
    Sensitive
    :
    A1
    No biomarker
    Soft Tissue Sarcoma
    doxorubicin hydrochloride
    Sensitive
    :
    A1
    No biomarker
    Soft Tissue Sarcoma
    ifosfamide + epirubicin + mesna
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    AIM
    Sensitive
    :
    A2
    NTRK3 fusion
    Soft Tissue Sarcoma
    entrectinib
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    GT
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    ifosfamide
    Sensitive
    :
    A2
    NTRK1 fusion
    Soft Tissue Sarcoma
    larotrectinib
    Sensitive
    :
    A2
    NTRK3 fusion
    Soft Tissue Sarcoma
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Soft Tissue Sarcoma
    larotrectinib
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    gemcitabine + dacarbazine
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    cediranib
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    sunitinib
    Sensitive
    :
    A2
    ALK translocation
    Soft Tissue Sarcoma
    crizotinib
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    regorafenib
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    ifosfamide + pegylated liposomal doxorubicin
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    temozolomide
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    dacarbazine
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    gemcitabine + vinorelbine tartrate
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    gemcitabine
    Sensitive
    :
    A2
    No biomarker
    Soft Tissue Sarcoma
    doxorubicin hydrochloride + ifosfamide + dacarbazine + mesna
    Sensitive
    :
    A2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES